- Home
- RLMD vs NOTE Comparison
RLMD vs NOTE Comparison
Compare RLMD & NOTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLMD
- NOTE
- Stock Information
- Founded
- RLMD 2004
- NOTE 2013
- Country
- RLMD United States
- NOTE United States
- Employees
- RLMD N/A
- NOTE N/A
- Industry
- RLMD Biotechnology: Pharmaceutical Preparations
- NOTE EDP Services
- Sector
- RLMD Health Care
- NOTE Technology
- Exchange
- RLMD Nasdaq
- NOTE Nasdaq
- Market Cap
- RLMD 66.7M
- NOTE 65.4M
- IPO Year
- RLMD N/A
- NOTE N/A
- Fundamental
- Price
- RLMD $1.99
- NOTE $5.07
- Analyst Decision
- RLMD Hold
- NOTE Strong Buy
- Analyst Count
- RLMD 2
- NOTE 4
- Target Price
- RLMD $1.00
- NOTE $29.25
- AVG Volume (30 Days)
- RLMD 517.7K
- NOTE 287.9K
- Earning Date
- RLMD 11-06-2025
- NOTE 11-11-2025
- Dividend Yield
- RLMD N/A
- NOTE N/A
- EPS Growth
- RLMD N/A
- NOTE N/A
- EPS
- RLMD N/A
- NOTE N/A
- Revenue
- RLMD N/A
- NOTE $109,683,000.00
- Revenue This Year
- RLMD N/A
- NOTE N/A
- Revenue Next Year
- RLMD N/A
- NOTE $41.76
- P/E Ratio
- RLMD N/A
- NOTE N/A
- Revenue Growth
- RLMD N/A
- NOTE N/A
- 52 Week Low
- RLMD $0.24
- NOTE $3.80
- 52 Week High
- RLMD $3.98
- NOTE $24.36
- Technical
- Relative Strength Index (RSI)
- RLMD 59.73
- NOTE 68.03
- Support Level
- RLMD $1.89
- NOTE $4.90
- Resistance Level
- RLMD $2.84
- NOTE $5.56
- Average True Range (ATR)
- RLMD 0.28
- NOTE 0.36
- MACD
- RLMD 0.01
- NOTE -0.09
- Stochastic Oscillator
- RLMD 37.96
- NOTE 60.97
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.
About NOTE FiscalNote Holdings Inc.
FiscalNote Holdings Inc is a provider of world-wide policy and market intelligence solutions. Leveraging AI and analytics, it delivers actionable legal and policy insights for businesses, government institutions, and nonprofits. Its suite of products includes FiscalNote Core, CQ Federal, and EU Issue Tracker, facilitating effective policy management and risk mitigation. With its analysis from FrontierView, Oxford Analytica, and Dragonfly Eye, it offers geopolitical and market intelligence services. Operating as one segment, it generates revenue by integrating policy intelligence into daily operations. Geographically the company generates the majority of its revenue from North America, Europe, Australia, and Asia, with the majority generated from North America.